Literature DB >> 23546775

A novel knowledge representation framework for the statistical validation of quantitative imaging biomarkers.

Andrew J Buckler1, David Paik, Matt Ouellette, Jovanna Danagoulian, Gary Wernsing, Baris E Suzek.   

Abstract

Quantitative imaging biomarkers are of particular interest in drug development for their potential to accelerate the drug development pipeline. The lack of consensus methods and carefully characterized performance hampers the widespread availability of these quantitative measures. A framework to support collaborative work on quantitative imaging biomarkers would entail advanced statistical techniques, the development of controlled vocabularies, and a service-oriented architecture for processing large image archives. Until now, this framework has not been developed. With the availability of tools for automatic ontology-based annotation of datasets, coupled with image archives, and a means for batch selection and processing of image and clinical data, imaging will go through a similar increase in capability analogous to what advanced genetic profiling techniques have brought to molecular biology. We report on our current progress on developing an informatics infrastructure to store, query, and retrieve imaging biomarker data across a wide range of resources in a semantically meaningful way that facilitates the collaborative development and validation of potential imaging biomarkers by many stakeholders. Specifically, we describe the semantic components of our system, QI-Bench, that are used to specify and support experimental activities for statistical validation in quantitative imaging.

Mesh:

Substances:

Year:  2013        PMID: 23546775      PMCID: PMC3705009          DOI: 10.1007/s10278-013-9598-3

Source DB:  PubMed          Journal:  J Digit Imaging        ISSN: 0897-1889            Impact factor:   4.056


  51 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

Review 2.  FDG-PET and beyond: molecular breast cancer imaging.

Authors:  Andrew Quon; Sanjiv S Gambhir
Journal:  J Clin Oncol       Date:  2005-03-10       Impact factor: 44.544

Review 3.  Using imaging biomarkers to accelerate drug development and clinical trials.

Authors:  Homer H Pien; Alan J Fischman; James H Thrall; A Gregory Sorensen
Journal:  Drug Discov Today       Date:  2005-02-15       Impact factor: 7.851

4.  Surrogate endpoints and FDA's accelerated approval process.

Authors:  Thomas R Fleming
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Feb       Impact factor: 6.301

Review 5.  The FDA critical path initiative and its influence on new drug development.

Authors:  Janet Woodcock; Raymond Woosley
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

Review 6.  Considerations for the use of imaging tools for phase II treatment trials in oncology.

Authors:  Lalitha K Shankar; Annick Van den Abbeele; Jeff Yap; Robert Benjamin; Scott Scheutze; T J Fitzgerald
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

7.  Toward verified biological models.

Authors:  Avital Sadot; Jasmin Fisher; Dan Barak; Yishai Admanit; Michael J Stern; E Jane Albert Hubbard; David Harel
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2008 Apr-Jun       Impact factor: 3.710

8.  The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?".

Authors:  Susanna-Assunta Sansone; Philippe Rocca-Serra; Marco Brandizi; Alvis Brazma; Dawn Field; Jennifer Fostel; Andrew G Garrow; Jack Gilbert; Federico Goodsaid; Nigel Hardy; Phil Jones; Allyson Lister; Michael Miller; Norman Morrison; Tim Rayner; Nataliya Sklyar; Chris Taylor; Weida Tong; Guy Warner; Stefan Wiemann
Journal:  OMICS       Date:  2008-06

9.  The Semantic Automated Discovery and Integration (SADI) Web service Design-Pattern, API and Reference Implementation.

Authors:  Mark D Wilkinson; Benjamin Vandervalk; Luke McCarthy
Journal:  J Biomed Semantics       Date:  2011-10-24

10.  Knowledge management for systems biology a general and visually driven framework applied to translational medicine.

Authors:  Dieter Maier; Wenzel Kalus; Martin Wolff; Susana G Kalko; Josep Roca; Igor Marin de Mas; Nil Turan; Marta Cascante; Francesco Falciani; Miguel Hernandez; Jordi Villà-Freixa; Sascha Losko
Journal:  BMC Syst Biol       Date:  2011-03-05
View more
  1 in total

Review 1.  Methods and challenges in quantitative imaging biomarker development.

Authors:  Richard G Abramson; Kirsteen R Burton; John-Paul J Yu; Ernest M Scalzetti; Thomas E Yankeelov; Andrew B Rosenkrantz; Mishal Mendiratta-Lala; Brian J Bartholmai; Dhakshinamoorthy Ganeshan; Leon Lenchik; Rathan M Subramaniam
Journal:  Acad Radiol       Date:  2015-01       Impact factor: 3.173

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.